Cite
HARVARD Citation
Ribas, A. et al. (n.d.). 1265PPhase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy. Annals of oncology. p. . [Online].